Renal Physiology for the Boards – Melanie P. Hoenig, MD

Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD

Question and Answer Session – Faculty

Renal Pathology in 2021: Part 1 Nephritic Conditions – Helmut G. Rennke, MD

Renal Pathology in 2021: Part 2 – Astrid Weins, MD, PhD

Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD

Question and Answer Session – Faculty

IgA Nephropathy – Gerald B. Appel, MD

Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD

ANCA Vasculitis – John L. Niles, MD

Question and Answer Session – Faculty

Update on Lupus Nephritis – Gerald B. Appel, MD

Metabolic Management of Kidney Stones – Gary C. Curhan, MD, ScD

Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA

Question and Answer Session – Faculty

Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD

Must-Know Clinical Images in Nephrology – Ajay K.. Singh, MBBS, FRCP (UK), MBA

Must-Know Board Zebras – Emily S. Robinson, MD, MPH

Nephrology Board Review Practice 1 – Finnian R. McCausland, MB BCh, MMSc, FRCPI

Nephrology Board Review Practice 2 – Mallika Mendu, MD, MBA

Hyponatremia and Hypernatremia – Sodium Disorders – David B. Mount, MD

Hypokalemia and Hyperkalemia – Potassium Disorders – David B. Mount, MD

Question and Answer Session – Faculty

Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir

Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, BChir

Question and Answer Session – Faculty

Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH

Treating Renal Patients with Rituximab in the Era of COVID-19 – David B. Mount, MD

Genetics and Kidney Disease – Friedhelm Hildebrandt, MD

Update on Polycystic Kidney Disease – Cristian Riella, MD

Question and Answer Session – Faculty

Pediatric Nephrology – Michael J.G. Somers, MD

Genetics: How to Integrate It into Practice – Ali Gharavi, MD

Social Determinants/Disparities in Renal Disease – Winfred W. Williams, Jr., MD

Question and Answer Session – Faculty

Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, BChir

Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, BChir

Chronic Kidney Disease in the Community: Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP

SPECIAL LECTURE — End-Stage Renal Disease in Areas of Armed Conflict: Challenges and Solutions – Sahar Koubar, MD

Why Do We Reject a Transplant? – Jamil R. Azzi, MD

Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP

Question and Answer Session – Faculty

Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD

Early Post-Transplant Management – Anil K. Chandraker, MD

Question and Answer Session – Faculty

Evaluation of the Kidney Living Donor – Kassem Safa, MD

Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD

Infections in Transplant Recipients – Sarah P. Hammond, MD

Monitoring Kidney Transplant Patients: Beyond Creatinine – Saif Abdulkarim Muhsin, MB BCh

Pre-Transplant Surgical Evaluation of Recipients – Jamil R. Azzi, MD

Question and Answer Session – Faculty

Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD

Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD

Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD

Geriatric Nephrology – Ernest I. Mandel, MD

COVID-19 Vaccination Response in Transplant Patients – Ann Woolley, MD

Immunologic Basis of Kidney Disease – Vivek Kasinath, MD

Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD

Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD

Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD

Transplant Board Review – Anil K. Chandraker, MD

Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh

Management of Hypertension after SPRINT – Richard J. Glassock, MD

Question and Answer Session – Faculty

Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc

Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI

Liver and the Kidney – Andrew S. Allegretti, MD, MSc

Question and Answer Session – Faculty

Update on Renovascular Disease – Joseph M. Garasic, MD

Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD

Acute Kidney Injury Syndromes – Alice M. Sheridan, MD

ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh

Question and Answer Session – Faculty

Cancer and Acute Kidney Injury – Albert Q. Lam, MD

Paraprotein Induced Kidney Injury – Albert Q. Lam, MD

FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD

Interstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH

APOL1 and Kidney Disease – Martin R. Pollak, MD

Question and Answer Session – Faculty

Dialysis Dosing – J. Kevin Tucker, MD

Mineral and Bone Disease – David Bushinsky, MD

Question and Answer Session – Faculty

Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD

Pearls in Mineral and Bone Disease – David Bushinsky, MD

Chronic Kidney Disease Epidemiology: A 2021 Update – Gearoid M. McMahon, MB BCh

Question and Answer Session – Faculty

Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC

Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC

COVID-19 and Kidney Disease – Daniel Batlle, MD

Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD

Dialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD

Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD

Question and Answer Session – Faculty